Correlation Between Active Biotech and Oncopeptides

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Active Biotech and Oncopeptides at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Active Biotech and Oncopeptides into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Active Biotech AB and Oncopeptides AB, you can compare the effects of market volatilities on Active Biotech and Oncopeptides and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Active Biotech with a short position of Oncopeptides. Check out your portfolio center. Please also check ongoing floating volatility patterns of Active Biotech and Oncopeptides.

Diversification Opportunities for Active Biotech and Oncopeptides

0.31
  Correlation Coefficient

Weak diversification

The 3 months correlation between Active and Oncopeptides is 0.31. Overlapping area represents the amount of risk that can be diversified away by holding Active Biotech AB and Oncopeptides AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Oncopeptides AB and Active Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Active Biotech AB are associated (or correlated) with Oncopeptides. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Oncopeptides AB has no effect on the direction of Active Biotech i.e., Active Biotech and Oncopeptides go up and down completely randomly.

Pair Corralation between Active Biotech and Oncopeptides

Assuming the 90 days trading horizon Active Biotech AB is expected to generate 3.58 times more return on investment than Oncopeptides. However, Active Biotech is 3.58 times more volatile than Oncopeptides AB. It trades about 0.15 of its potential returns per unit of risk. Oncopeptides AB is currently generating about -0.16 per unit of risk. If you would invest  19.00  in Active Biotech AB on September 1, 2024 and sell it today you would earn a total of  8.00  from holding Active Biotech AB or generate 42.11% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Active Biotech AB  vs.  Oncopeptides AB

 Performance 
       Timeline  
Active Biotech AB 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Active Biotech AB are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Active Biotech unveiled solid returns over the last few months and may actually be approaching a breakup point.
Oncopeptides AB 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Oncopeptides AB has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Active Biotech and Oncopeptides Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Active Biotech and Oncopeptides

The main advantage of trading using opposite Active Biotech and Oncopeptides positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Active Biotech position performs unexpectedly, Oncopeptides can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Oncopeptides will offset losses from the drop in Oncopeptides' long position.
The idea behind Active Biotech AB and Oncopeptides AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.

Other Complementary Tools

Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes